Day: April 6, 2021

EDDA Technology Announces US$150 Million Financing Round, led by Softbank Vision Fund 2, with OrbiMed Participation, to Advance Intelligent Robotic Solutions for Precision Surgery

SHANGHAI and SUZHOU, China, April 7, 2021 /PRNewswire/ — EDDA Healthcare and Technology Holding Ltd. and its subsidiaries EDDA Technology (Shanghai) Ltd., EDDA Technology Medical Solutions (Suzhou) Ltd., and EDDA Technology, Inc (Princeton, NJ, USA), (hereafter jointly referred to as EDDA Technology), a pioneer in the rapidly growing field of intelligent robotic solutions for precision […]

Dave Grohl Is Publishing His First Book This Year

Dave Grohl revealed he’s filled to the brim with hectic stories last year. Bored of the pandemic, he created an Instagram page, specifically to share some of those stories. On Dave’s True Stories, Grohl said at the time, “I’m currently looking for work. So I thought I’d pass the time by writing true stories that […]

Essence Group Major Supply Chain Initiative Helps Ensure Continued Customer Service for its Partners Throughout COVID-19 Lockdown

HERZLIYA, Israel, April 7, 2021 /PRNewswire/ — Essence Group, a leading provider of IoT solutions for the global security and care markets, today provided details of its aggressive supply chain initiative, that mitigated the global supply chain disruption caused by COVID-19 and ensured the continued supply of its complex multi-component products to key partner, Verisure, a […]

Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-176 in EGFR-Mutant NSCLC with C797S

SEONGNAM, South Korea, April 7, 2021 /PRNewswire/ — Bridge Biotherapeutics Inc.(288330 KQ), a clinical-stage biotech company headquartered in Seongnam, Republic of Korea, announced that the company has initiated the Phase 1/2 clinical trial assessing safety, tolerability, and anti-tumor activity of BBT-176 in non-small cell lung cancer (NSCLC) patients who acquired osimertinib-resistant EGFR triple mutations. BBT-176, a novel […]

Renren Announces a $6 Million Equity Investment in Kaixin Auto

BEIJING, April 7, 2021 /PRNewswire/ — Renren Inc. (NYSE: RENN) (“Renren” or the “Company”) announced today that Renren has made a $6,000,000 equity investment in Kaixin by subscribing Kaixin Auto Holdings’ (“Kaixin”) newly designated convertible preferred shares. The preferred shares are convertible into Kaixin’s ordinary shares at a conversion price of $3.00, subject to customary adjustments pursuant […]

Back To Top